Biotech patents on the scales

patent by Clearly Ambiguous
Biotech Battles at the U.S. Patent Office?:
[Via AAAS News – RSS Feed]

Shobita Parthasarathy: Battles Brewing as Public Questions Biotech’s Living Inventions

More challenges to biotech patents may be in store as advocacy groups raise broad questions about the creation of modified life forms, a leading expert said at AAAS.

[More]

There may be a lot of patent battles on the horizon, with these will be coming from the patient side of things rather than from other corporations. With all the other changes on the horizon for the pharmaceutical industry, uncertain IP issues are not something they will want to have to deal with.

There seems to be much more of a moral/ethical component to some of these arguments rather than simply monetary. Europe has been doing this and the US patent office may be invoking this more and more as citizen activists push back against the Patent Office.

Technorati Tags: